Sarcomas of the nose and paranasal sinuses are rare malignancies. Because of their rarity, diversity of type, and absence of uniform criteria of classification and staging, there is a lack of meaningful data regarding their clinical behavior, treatment, and prognosis. To help clarify these issuese, 18 cases of nasal and paranasal sinus sarcomas treated at our department between Jan. 1970 and June 1994 were retrospectively reviewed. One of the patients was managed with radiotherapy alone. The others were treated with surgery combined with post-operative radiotherapy. Some of them received chemotherapy. The patients with aggressive histologictypes such as rhabdomyosarcoma and malignant fibrohistiocytoma experienced the poorest outcome. High grade lesions place the patients at risk for local recurrence and distant dissemination. The 2-year and 5-year survival rates were 39% and 27%, respectively. The surgical margin status was found to be significantly related to the local control and outcome for sinonasal sarcomas. Patients with sinonasal sarcomas should undergo wide excision with the removal of all gross disease and the acquisition of negative, microscopic surgicalmargins. Patients with positive surgical margins should be treated with postoperative radiotherapy if reexcision is no possible.